Transit accessibility is an important measure on the service performance of transit systems. To assess whether the public transit service is well accessible for trips of specific origins, destinations, and origin-destination (OD) pairs, a novel measure, the Trip Coverage Index (TCI), is proposed in this paper. TCI considers both the transit trip coverage and spatial distribution of individual travel demands. Massive trips between cellular base stations are estimated by using over four-million mobile phone users. An easy-to-implement method is also developed to extract the transit information and driving routes for millions of requests. Then the trip coverage of each OD pair is calculated. For demonstrative purposes, TCI is applied to the transit network of Hangzhou, China. The results show that TCI represents the better transit trip coverage and provides a more powerful assessment tool of transit quality of service. Since the calculation is based on trips of all modes, but not only the transit trips, TCI offers an overall accessibility for the transit system performance. It enables decision makers to assess transit accessibility in a finer-grained manner on the individual trip level and can be well transformed to measure transit services of other cities.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2lEO9GH
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2jCvX3K via IFTTT
-
Treatment effectiveness holds considerable importance in the association between service quality and satisfaction in medical service studies...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2pbGdiN via IFTTT
-
Vol.25 No.2 from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1P7bHxT via IFTTT
-
Publication date: Available online 16 January 2017 Source: International Journal of Pediatric Otorhinolaryngology Author(s): Kaveh Karimn...
-
Daily Mail Sarah was diagnosed with the cancer that killed Steve Jobs Daily Mail The symptoms Sarah Smith experienced on and off for...
-
Omalizumab is a treatment for asthma that has a success rate of approximately 40% to 50%.1 Recent mechanistic studies have suggested that ba...
-
Understanding Head And Neck Cancers - The Southeast Sun ... The Southeast Sun (NAPSI)—According to the Centers for Disease Control an...
-
Abstract Background Henoch–Schönlein purpura is the most common vasculitis in children. Its long-term prognosis depends on renal involve...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου